Applications of DL-2-Bromohexanoic Acid in Industrial Manufacturing

As a direct manufacturer specializing in DL-2-Bromohexanoic Acid, we supply this intermediate to various sectors with proven utility in specialty chemical synthesis and custom molecule manufacturing. The applications below represent mainstream downstream industries making practical, specification-driven use of this material. Each scenario details the relevant regulatory environment, formulation standards, integration into actual industrial processes, and finished goods resulting from its controlled application.

1. Custom Synthesis of Pharmaceutical Intermediates

DL-2-Bromohexanoic Acid serves as a building block in the synthesis of several active pharmaceutical ingredients, especially those containing chiral or bromo-functionalized side chains. Its role centers on introducing brominated aliphatic segments in target molecules, with close monitoring to ensure structural integrity and GMP compliance throughout. Production facilities incorporate this intermediate at the initial alkylation or acylation stages before progressing to further chemical transformation, facilitated by its defined purity profile and reactivity. The precise usage and compliance must match the requirements for downstream registration and regulatory inspection, as end-pharma production demands traceability from raw material through to final active substance batches.

Industry compliance standards

• ICH Q7 GMP for Active Pharmaceutical Ingredients
• EU EudraLex Volume 4 GMP Guidelines
• US FDA 21 CFR Part 211
• ISO 9001:2015 Quality Management Systems

Typical usage ratio

• Employed at 1.2–2.0 molar equivalents relative to core substrate per batch synthesis; adjusted based on targeted bromination level and impurity control as specified in each API’s route of synthesis.

Downstream process integration

• Added at the alkylation/acylation step during intermediate synthesis, under strictly controlled conditions with in-process QC sampling for conversion and impurity profiling before work-up/neutralization.

Final product types

• Small-molecule pharmaceutical intermediates containing brominated hexanoic acid moieties
• Chiral drug precursors for further asymmetric synthesis
• Target molecules for registration batches used in regulatory submissions

2. Agrochemical Active Ingredient Synthesis

Within the agrochemical industry, this acid is utilized in the preparation of specialized herbicide and fungicide active ingredients, where its six-carbon chain and bromo-functionality introduce targeted bioactivity to the molecule. Agrochemical syntheses require strict adherence to regulations relating to environmental health, and the raw material’s batch traceability is essential. DL-2-Bromohexanoic Acid is incorporated during key sidechain functionalization steps, with formulation and handling adjusted for environmental controls and downstream formulation compatibility.

Industry compliance standards

• OECD Good Laboratory Practice (GLP) Principles
• FAO/WHO Guidelines for the Registration and Control of Pesticides
• REACH (EC 1907/2006) Registration for agro intermediates
• ISO 9001:2015 Quality Management Systems

Typical usage ratio

• Used at 0.85–1.1 molar equivalents relative to the targeted active base structure; final usage ratio tailored to minimize residual starting materials and ensure full conversion in the multi-step synthesis.

Downstream process integration

• Introduced post-halogenation during intermediate coupling, under monitored temperature and pH for selectivity and to limit by-product formation; final intermediate processed directly toward target agrochemical actives.

Final product types

• Herbicide active ingredient intermediates with bromo-aliphatic structures
• Fungicide sidechain precursors for further derivatization in final formulation steps
• Controlled-release pesticide molecules

3. Synthesis of Specialty Surfactants and Emulsifiers

Manufacturers of specialty surfactants employ DL-2-Bromohexanoic Acid to build tailor-made lactone or ether linkages within their product platforms. The bromo-end group enables site-selective modifications, making it possible to create unique emulsifiers for water/oil systems used in industrial and cosmetic applications. Strict process validation and compositional analysis are performed during downstream production to ensure that the molecular structure meets end-use performance targets while maintaining compliance with chemical registration and safety legislation, including those specific to consumer contact materials.

Industry compliance standards

• REACH (EC 1907/2006) for surfactant registration
• EU Detergents Regulation (EC) No 648/2004
• ISO 9001:2015 Quality Management Systems
• IFRA Standards (where used in fragrance-carrying systems)

Typical usage ratio

• 0.5–2.5% w/w in the reaction mixture, defined by chain-length design of the surfactant or co-emulsifier; determined by targeted HLB (Hydrophilic-Lipophilic Balance) and phase behavior of the final product.

Downstream process integration

• Reacted in the core alkylation or ring-closing step, then neutralized and purified. The modified product is subsequently blended with other surfactant systems or further functionalized, depending on application requirements.

Final product types

• Nonionic surfactants for industrial emulsions and dispersions
• Intermediate emulsifiers for cosmetic and personal care formulations
• Reactive surfactant monomers for advanced polymer dispersions

4. Manufacture of Specialty Polymers and Polymeric Additives

DL-2-Bromohexanoic Acid is leveraged in polymer research and specialty polymer manufacturing for incorporating bromo-functional side chains or initiating grafting reactions. It is specifically introduced into polymer backbones to create reactive or functional handles, essential for advanced material development in coatings, compatibilizers, or biomedical carriers. Strict quantitative feed and in-line analytical tools such as NMR or GCMS verify the integration of the monomeric building block under defined thermal and mixing profiles as required by the downstream polymerization mechanism.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems
• EFfCI GMP (where applied for cosmetic or pharma-grade polymer additives)
• REACH (EC 1907/2006) Polymer exemption/restriction rules
• ASTM D7581 (polymer composition analysis)

Typical usage ratio

• 0.1–1.5% molar ratio in the monomer feed, depending on the degree of functionalization required; percentage defined by product specification and customer performance parameters for the polymer end-use.

Downstream process integration

• Charged into initial copolymerization reactors or as a post-polymer grafting agent, with reaction endpoint determined by targeted chain length and functional group density, followed by in-process purification and performance validation.

Final product types

• Specialty copolymers with bromo-functional side chains for industrial coatings
• Compatibilizing polymeric additives for compound formulations
• Biomedical polymer precursors